Arvinas logo



Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.


Add photos to showcase Arvinas’s culture


Add Arvinas’s values

Insider experiences

Share your experience of working at Arvinas

John Houston
President & CEO
John Northcott
Chief Commercial Officer
Ron Peck
Chief Medical Officer
Ian Taylor
Chief Scientific Officer
Lisa Sinclair
SVP, Corporate Operations
Angela M. Cacace
VP, Neuroscience & Platform Biology
John A. Grosso
VP, Chemistry, Manufacturing, & Controls
Kimberly Wehger
VP, Information Technology
Marcia Dougan Moore
VP, Development Operations
Matthew Batters
VP, Business Development & Counsel
Randy Teel
VP, Corporate Development
Steve Weiss
VP, Human Resources
Debbie Chirnomas
VP, Oncology Clinical Research
Jeff Boyle
VP, Investor Relations
Larry Snyder
VP, Medicinal Chemistry
Eric Masson
VP, Early Clinical Development
Christina Sheil
VP, Pharmacovigilance

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure